40th Pharmacovigilance UK & EU 2026
40th Pharmacovigilance UK & EU 2026
11 & 12 March 2026
Sheraton Skyline, Heathrow, London, UK
5 Reasons to attend the event
Knowledge
Gain insights from experts, researchers, and professionals to stay updated on the latest pharma advancements.
An Agenda Made For You
High quality content that addresses your biggest challenges and uncovering hidden opportunities.
Cutting-Edge Insights
Discover the latest trends, innovations, and breakthroughs shaping the future of the pharmaceutical industry.
Networking
Connect with peers, industry leaders, and collaborators to exchange ideas and explore new opportunities.
Practical Takeaways
Walk away with actionable strategies, real-world case studies, and learn best practices to implement in your work.
Knowledge
Gain insights from experts, researchers, and professionals on the latest pharma advancements.
An Agenda Made For You
High quality content that addresses your biggest challenges and uncovering hidden opportunities.
Cutting-Edge Insights
Explore the latest trends, innovations, and breakthroughs driving the future of the pharmaceutical industry.
Networking
Connect with peers, industry leaders, and collaborators to exchange ideas and explore new opportunities.
Practical Takeaways
Walk away with practical strategies, case studies, and proven best practices to apply in real-time.
Key Focus Areas
Event Speakers
KARSTEN LOLLIKE
Novo Nordisk
STEPHANIE MILLICAN
MHRA
MICHAEL BEAN
Johnson & Johnson
JEAN-MARC HAUSLER
F. Hoffmann-La Roche
CHETAN SHATAPATHY
AstraZeneca
LEONA HOUGHTON
Mundipharma
MIRCEA CIUCA
Organon (Former)
MIJAL CHAVDA
Kyowa Kirin
REMCO M. DIAB
Former Sanofi
JUDY BARRETTO
Gilead Sciences
CHRISTIAN MUHL
GSK
MARIJA SIMIC
Sandoz
PAV RISHIRAJ
Ipsen
CALVIN JOHNSON
Bristol-Myers Squibb
JASON BRYANT
ArisGlobal
HUMAIRA QURESHI
Arriello
MALIN KREITZ
Ultragenic Research and Technologies
YVONNE NANCIU
Bayer
HOWARD ABROMS
Soterius
PUNAM KUMARI
Biovance Solutions
RACHEL MCDERMOTT
Shionogi Europe
TEA BABIC
Teva
TERESA SARAGOCA
ITALFARMACO
SABINE POLTERMANN
Bristol-Myers Squibb
GAYATHRI SUBBURAMAN
Menarini Stemline
JOHN SOLOMON
Sanofi (Former)
BEGUM BENLI PEKER
Bristol-Myers Squibb
SUMIT MUNJAL
Otsuka Pharmaceuticals
PHILLIP EICHORN
Amryt Pharma
ABIDALI FAZAL
Roche
MARJAN DZEPAROSKI
Bionika Pharmaceuticals
SHIKTA DAS
AstraZeneca
RUDI SCHEERLINCK
Healthcare Business of Merck
MICHAEL VON FORSTNER
MedGenie
GURPREET SINGH
IQVIA
PETAR GJORGIEV
Regeneron
LEONARDO PEREIRA
Roche
ZINA SADEQ
Amicus Therapeutics
SANJEEV SRIVASTAV
BioNTech
MAYUR PATEL
PA Consulting
Download Brochure
Event Schedule
Meet to learn and network with your conference colleagues.
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:15 – Opening Remarks / Welcome Address
09:30 – Chairperson opening remarks
Speaker
PAV RISHIRAJ
Director, Pharmacovigilance & UK QPPV | ABPI PV Expert Chair
Ipsen
09:40 – Beyond compliance: How we can do more for patients in PV
BEYOND COMPLIANCE
Patient voices in PV are still underutilized. We can move beyond compliance and do our best to make safety truly patient-centered.
This presentation will cover the current state, why it matters to include patient voices and how we can do more and move from “checking the box” to doing our best for patients.
Speaker
BEGUM BENLI PEKER
Head of Patient Safety EU Hub
Bristol-Myers Squibb
10:20 – Safety monitoring in clinical studies
SAFETY
- Proactive monitoring
- Timely detection and management of safety issues
- Interaction & communication with stakeholders.
Speaker
RUDI SCHEERLINCK
Safety Strategy Lead – Oncology
Healthcare Business of Merck
10:50 – Morning Coffee/Tea & Networking
11:20 – Agentic AI in Pharmacovigilance: From Task Automation to Unified Data Intelligence
This session examines the structural shift in pharmacovigilance from task automation toward bounded, coordinated agentic systems operating on unified data and knowledge foundations. Drawing on emerging architectural patterns, it outlines how decision intelligence elevates insight, context, and cross-functional coherence across safety and regulatory domains.
JASON BRYANT
SVP, Product Management, AI
ArisGlobal
11:50 – Keynote Panel Discussion: Pharmacovigilance: Innovations, Challenges & Global Best Practices - Best practices & the way forward
LATEST UPDATES & HOT TOPICS
Moderator
RUDI SCHEERLINCK
Safety Strategy Lead – Oncology
Healthcare Business of Merck
Panellists
REMCO M. DIAB
Global Head of PV, Science and Medical Affairs
Former Sanofi
MARIJA SIMIC
Director Medical Safety Team Lead Global Patient Safety
Sandoz
LEONARDO PEREIRA
Clinical Safety Director
Roche
RACHEL MCDERMOTT
Senior Safety physician
Shionogi Europe
12:50 – Networking luncheon
13:50 – Panel Discussion – Patient-Centric PV: Elevating Drug Safety through Engagement. Making drug safety monitoring more proactive, data-driven, and human-centered
PATIENT CENTRIC PV
Moderator
YVONNE NANCIU
Country Head Pharmacovigilance Deputy EU QPPV
Bayer
Panellists
ABIDALI FAZAL
Safety Science Director
Roche
SUMIT MUNJAL
Global Head of Medical Safety
Otsuka Pharmaceuticals
PUNAM KUMARI
MICHAEL VON FORSTNER
Chief Scientific Officer
MedGenie
14:50 – Designing PV Systems for Humans and Agentic AI: A Risk-Based Path from HITL to HOTL
- Responsible system design for agentic AI in regulated Pharmacovigilance.
- The talk will outline a risk-based, regulatory-aligned approach to designing hybrid systems where humans and agentic AI are treated as equal system actors, with built-in explainability, auditability, fairness in line with CIOMS principles, and continuous model evaluation and replaceability.
Speaker
MALIN KREITZ
Director of European Operations
Ultragenic Research and Technologies
15:10 – Afternoon Tea/Coffee
15:40 – Topic TBC
Speaker TBC
Speaker
RAGHDA MOHAMED
Patient Safety Cluster Lead – Middle East & Turkey / Global patient Safety Evaluation
Takeda Pharmaceuticals
16:10 - Panel Discussion – The Evolving Era of PV Outsourcing: Recent Developments, Innovations and Best Practices
OUTSOURCING
Moderator
PAV RISHIRAJ
Director, Pharmacovigilance & UK QPPV | ABPI PV Expert Chair
Ipsen
Panellists
LEONA HOUGHTON
Vice President, Global Safety (Ex-US)
Mundipharma
ZINA SADEQ
Director, Regional PV & Alliance Management, UK QPPV
Amicus Therapeutics
PHILLIP EICHORN
Global Head of Drug Safety
Amryt Pharma
GURPREET SINGH
Vice President, Managing Director Integrated Safety,
IQVIA
GAYATHRI SUBBURAMAN
Senior Director, Global Safety Lead
Menarini Stemline
HOWARD ABROMS
VP – Global Business Development
Soterius
17:00 - Chairperson’s closing remarks and end of conference
17:10 – 18:10 - Networking Drinks Session
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:15 – Opening Remarks / Welcome Address
09:30 – Chairperson opening remarks
Speaker
PAV RISHIRAJ
Director, Pharmacovigilance & UK QPPV | ABPI PV Expert Chair
Ipsen
09:40 – Beyond compliance: How we can do more for patients in PV
BEYOND COMPLIANCE
Patient voices in PV are still underutilized. We can move beyond compliance and do our best to make safety truly patient-centered.
This presentation will cover the current state, why it matters to include patient voices and how we can do more and move from “checking the box” to doing our best for patients.
Speaker
BEGUM BENLI PEKER
Head of Patient Safety EU Hub
Bristol-Myers Squibb
10:20 – Safety monitoring in clinical studies
SAFETY
- Proactive monitoring
- Timely detection and management of safety issues
- Interaction & communication with stakeholders.
Speaker
RUDI SCHEERLINCK
Safety Strategy Lead – Oncology
Healthcare Business of Merck
10:50 – Morning Coffee/Tea & Networking
11:20 – Agentic AI in Pharmacovigilance: From Task Automation to Unified Data Intelligence
This session examines the structural shift in pharmacovigilance from task automation toward bounded, coordinated agentic systems operating on unified data and knowledge foundations. Drawing on emerging architectural patterns, it outlines how decision intelligence elevates insight, context, and cross-functional coherence across safety and regulatory domains.
JASON BRYANT
SVP, Product Management, AI
ArisGlobal
11:50 – Keynote Panel Discussion: Pharmacovigilance: Innovations, Challenges & Global Best Practices - Best practices & the way forward
LATEST UPDATES & HOT TOPICS
Moderator
RUDI SCHEERLINCK
Safety Strategy Lead – Oncology
Healthcare Business of Merck
Panellists
REMCO M. DIAB
Global Head of PV, Science and Medical Affairs
Former Sanofi
MARIJA SIMIC
Director Medical Safety Team Lead Global Patient Safety
Sandoz
LEONARDO PEREIRA
Clinical Safety Director
Roche
RACHEL MCDERMOTT
Senior Safety physician
Shionogi Europe
12:50 – Networking luncheon
13:50 – Panel Discussion – Patient-Centric PV: Elevating Drug Safety through Engagement. Making drug safety monitoring more proactive, data-driven, and human-centered
PATIENT CENTRIC PV
Moderator
YVONNE NANCIU
Country Head Pharmacovigilance Deputy EU QPPV
Bayer
Panellists
ABIDALI FAZAL
Safety Science Director
Roche
SUMIT MUNJAL
Global Head of Medical Safety
Otsuka Pharmaceuticals
PUNAM KUMARI
MICHAEL VON FORSTNER
Chief Scientific Officer
MedGenie
CINTHYA GALICIA QUINTANAR
Senior Manager, Country Safety Lead
Pfizer
14:50 – Designing PV Systems for Humans and Agentic AI: A Risk-Based Path from HITL to HOTL
- Responsible system design for agentic AI in regulated Pharmacovigilance.
- The talk will outline a risk-based, regulatory-aligned approach to designing hybrid systems where humans and agentic AI are treated as equal system actors, with built-in explainability, auditability, fairness in line with CIOMS principles, and continuous model evaluation and replaceability.
Speaker
MALIN KREITZ
Director of European Operations
Ultragenic Research and Technologies
15:10 – Afternoon Tea/Coffee
15:40 – Future of pharmacovigilance - Making medicines safe in an increasingly complex world
MARKET TRENDS & WAY AHEAD
- Pharmacovigilance: What comes next for the industry?
- Transforming the science at the heart of pharmacovigilance
- Building trust and openness with technology
- Automating to innovate
- Does the shift towards emerging markets pose a risk to drug safety and biased data reports?
Speaker
RAGHDA MOHAMED
Patient Safety Cluster Lead – Middle East & Turkey / Global patient Safety Evaluation
Takeda Pharmaceuticals
16:10 - Panel Discussion – The Evolving Era of PV Outsourcing: Recent Developments, Innovations and Best Practices
OUTSOURCING
Moderator
PAV RISHIRAJ
Director, Pharmacovigilance & UK QPPV | ABPI PV Expert Chair
Ipsen
Panellists
LEONA HOUGHTON
Vice President, Global Safety (Ex-US)
Mundipharma
ZINA SADEQ
Director, Regional PV & Alliance Management, UK QPPV
Amicus Therapeutics
PHILLIP EICHORN
Global Head of Drug Safety
Amryt Pharma
GURPREET SINGH
Vice President, Managing Director Integrated Safety,
IQVIA
GAYATHRI SUBBURAMAN
Senior Director, Global Safety Lead
Menarini Stemline
HOWARD ABROMS
VP – Global Business Development
Soterius
17:00 - Chairperson’s closing remarks and end of conference
17:10 – 18:10 - Networking Drinks Session
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:10 – Chairperson opening remarks
Speaker
PAV RISHIRAJ
Director, Pharmacovigilance & UK QPPV | ABPI PV Expert Chair
Ipsen
09:20 – Beyond the Algorithm – The Human-AI Partnership in Pharmacovigilance
PV FOR FUTURE
- Examines common anxieties about AI replacing human roles in pharmacovigilance and reframes these concerns to highlight new opportunities.
- Demonstrates how rekindling childlike curiosity and creativity in adult professionals can happen.
- Discusses practical approaches for building transparent, accountable processes when integrating AI into safety practices.
- Emphasizes the irreplaceable value of human judgement, empathy, and imagination alongside evolving AI technologies.
Speaker
SABINE POLTERMANN
Head of Country Patient Safety Switzerland
Bristol-Myers Squibb
09:50 – Panel Discussion - Plan, Develop & Implement the PV Audit strategy plan. PV Inspection readiness: What to expect? How ready can we be?
AUDITS & INSPECTIONS
Moderator
MIJAL CHAVDA
Senior Director, Global Head of GxP Inspections & GVP Quality
Kyowa Kirin
Panellists
KARSTEN LOLLIKE
Scientific VP, Deputy QPPV, Global Patient Safety
Novo Nordisk
TEA BABIC
Director, PV Audits & Inspections
Teva
CHRISTIAN MUHL
Senior Director Compliance
GSK
HUMAIRA QURESHI
Chief Operating Officer
Arriello
10:30 – Planning and Managing Audits and Inspections- A service provider viewpoint
With the evolution of Pharmacovigilance through upskilling and restructuring and accelerated geo- expansion , how have Service Providers needed to adapt.What should good look like now ? What is the role of technology in Audit Management and how is the demand in local, regional and global representation being managed
Speaker
HUMAIRA QURESHI
Chief Operating Officer
Arriello
11:00 – Morning Coffee/Tea & Discussion
11:30 – Keynote Panel Discussion: Benefit-Risk Excellence: Innovative Approaches to Risk Management
RISK MANAGEMENT & PLANNING
Moderator
MIRCEA CIUCA
Independent PV Consultant / International PV Expert
(Former Global Head Medical Safety, Organon)
Panellists
CHETAN SHATAPATHY
Executive Director & Head, ADC Group, Patient Safety Oncology
AstraZeneca
JOHN SOLOMON
Former Head of Pharmacovigilance – UK & Ireland
Sanofi
12:20 – Combination Products: Important Considerations for Patient Safety
COMBINATION PRODUCTS
- Medical Device Vigilance vs Pharmacovigilance
- Design Control
- Risk Management
Speaker
JUDY BARRETTO
Senior Director, Virology TA, Patient Safety
Gilead Sciences
12:50 – Networking luncheon
13:40 – Panel Discussion: Harnessing RWD & RWE: Transforming the Future of Pharmacovigilance
RWD / RWE
Moderator
Signal Management Lead
Panellists
AstraZeneca
Director, Pharmacovigilance & UK QPPV | ABPI PV
Expert Chair,
14:20 - Harmonizing Local PV Activity to Improve Efficiency” with the accent on non_EU Countries (Balkan)
REGULATORY
Speaker
MARJAN DZEPAROSKI
Head of Regulatory Affairs, Drug Safety & Intelectual Property
Bionika Pharmaceuticals
14:40 – Panel Discussion: Regulatory Synergy in PV: Challenges, Opportunities & the Road Ahead
OUTSOURCING
Moderator
PAV RISHIRAJ
Director, Pharmacovigilance & UK QPPV | ABPI PV Expert Chair
Ipsen
Panellists
STEPHANIE MILLICAN
Deputy Director BRE II
MHRA
MICHAEL BEAN
Senior Director, Regulatory Compliance
Johnson & Johnson
CALVIN JOHNSON
Vice President, International Patient Safety
Bristol-Myers Squibb
TERESA SARAGOCA
Director, Regulatory Affairs & Technical Manager
ITALFARMACO
15:30 - Chairperson’s closing remarks
15:40 – Evening Tea/Coffee and end of the conference
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:00 – Chairperson opening remarks
Speaker
PAV RISHIRAJ
Director, Pharmacovigilance & UK QPPV | ABPI PV Expert Chair
Ipsen
09:10 – Beyond the Algorithm – The Human-AI Partnership in Pharmacovigilance
PV FOR FUTURE
- Examines common anxieties about AI replacing human roles in pharmacovigilance and reframes these concerns to highlight new opportunities.
- Demonstrates how rekindling childlike curiosity and creativity in adult professionals can happen.
- Discusses practical approaches for building transparent, accountable processes when integrating AI into safety practices.
- Emphasizes the irreplaceable value of human judgement, empathy, and imagination alongside evolving AI technologies.
Speaker
SABINE POLTERMANN
Head of Country Patient Safety Switzerland
Bristol-Myers Squibb
09:40 – Panel Discussion - Plan, Develop & Implement the PV Audit strategy plan. PV Inspection readiness: What to expect? How ready can we be?
AUDITS & INSPECTIONS
Moderator
MIJAL CHAVDA
Senior Director, Global Head of GxP Inspections & GVP Quality
Kyowa Kirin
Panellists
KARSTEN LOLLIKE
Scientific VP, Deputy QPPV, Global Patient Safety
Novo Nordisk
TEA BABIC
Director, PV Audits & Inspections
Teva
CHRISTIAN MUHL
Senior Director Compliance
GSK
GALINA CORDERO
Head of Pharmacovigilance Dept, QPPV
JSC Farmak
10:20 - Solution Provider Presentation
For sponsorship opportunities please contact info.uk@virtueinsight.com
10:40 – Morning Coffee/Tea & Discussion
11:00 – Keynote Panel Discussion: Benefit-Risk Excellence: Innovative Approaches to Risk Management
RISK MANAGEMENT & PLANNING
Moderator
MIRCEA CIUCA
Independent PV Consultant / International PV Expert
(Former Global Head Medical Safety, Organon)
Panellists
Senior Director Safety Development
CHETAN SHATAPATHY
Executive Director & Head, ADC Group, Patient Safety Oncology
AstraZeneca
JOHN SOLOMON
Former Head of Pharmacovigilance – UK & Ireland
Sanofi
11:50 – Combination Products: Important Considerations for Patient Safety
COMBINATION PRODUCTS
- Medical Device Vigilance vs Pharmacovigilance
- Design Control
- Risk Management
Speaker
JUDY BARRETTO
Senior Director, Virology TA, Patient Safety
Gilead Sciences
12:20 – Adverse Drug Reactions in Special Populations: Insights from Pregnant Women and Children”
- Overview of physiological and pharmacokinetic differences influencing ADRs in pregnancy and pediatrics
- Common ADR patterns observed in these populations and real-world case insights
- Gaps in clinical trials and evidence generation for women and children
- Challenges in detection, dose adjustment, and safe prescribing
- Strategies to strengthen pharmacovigilance systems for vulnerable populations
Speaker
REEM YASIN
Quality Assurance & PV Manager
Hawkary Pharmaceuticals
12:40 – Networking luncheon
13:40 – Panel Discussion: Harnessing RWD & RWE: Transforming the Future of Pharmacovigilance
RWD / RWE
Moderator
Signal Management Lead
Panellists
RAGHDA MOHAMED
Patient Safety Cluster Lead – Middle East & Turkey / Global
patient Safety Evaluation
Takeda Pharmaceuticals
AstraZeneca
14:20 - Harmonizing Local PV Activity to Improve Efficiency” with the accent on non_EU Countries (Balkan)
REGULATORY
Speaker
MARJAN DZEPAROSKI
Head of Regulatory Affairs, Drug Safety & Intelectual Property
Bionika Pharmaceuticals
14:40 – Panel Discussion: Regulatory Synergy in PV: Challenges, Opportunities & the Road Ahead
OUTSOURCING
Moderator
PAV RISHIRAJ
Director, Pharmacovigilance & UK QPPV | ABPI PV Expert Chair
Ipsen
Panellists
STEPHANIE MILLICAN
Deputy Director BRE II
MHRA
MICHAEL BEAN
Senior Director, Regulatory Compliance
Johnson & Johnson
CALVIN JOHNSON
Executive Director & Head of International Patient Safety
Bristol-Myers Squibb
TERESA SARAGOCA
Director, Regulatory Affairs & Technical Manager
ITALFARMACO
15:30 - Chairperson’s closing remarks
15:40 – Evening Tea/Coffee and end of the conference
Download Brochure
Book Your Place Now
We’re excited to welcome you to our upcoming event!
Payment Update
Our online booking system is currently being upgraded to provide you with a smoother and more secure experience.
The new payment gateway will go live in the next few days.
In the meantime, you can secure your spot using one of the two secure payment links below:
SUPER EARLY DISCOUNT (Till 11 Dec 25)
1 DELEGATE – £ 799 + VAT
3 DELEGATES – £ 1598 + VAT (3 for 2)
Note: All transactions are processed securely. Thank you for your patience while we improve our online system.
Should you have any queries you can simply email or call
TEL: +44 20 3509 3779 (or) Email — piyush@virtueinsightevents.com
CONFERENCE SPONSOR & EXHIBITION STALL
Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to:
TEL: +44 20 3509 3779 (or) Email — piyush@virtueinsightevents.com
Venue Details
The venue is easily accessible, well-equipped with modern amenities, and offers a comfortable, professional setting for all attendees.
Venue
Sheraton Skyline, Heathrow,
London, UK
Heathrow Airport, Sheraton Heathrow, A4 Bath Rd,
Harlington, Hayes UB3 5BP, United Kingdom
+44 20 8759 2535
Venue – Sheraton Skyline, Heathrow, London, UK
Heathrow Airport, Sheraton Heathrow, A4 Bath Rd, Harlington, Hayes UB3 5BP, United Kingdom
+44 20 8759 2535
